BODY ACTION PRODUCTS Butt Eze Benzocaine

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: BODY ACTION PRODUCTS Butt Eze Benzocaine
Generic name: BENZOCAINE
Manufacturer: PRODUCT MAX GROUP INC
Product type: HUMAN OTC DRUG
SPL set ID: ba75b129-7939-4373-91f5-1772976e6d61
SPL ID: 09d78ab6-7257-6e40-e063-6294a90aef3e
Version: 2
Effective date: 2023-11-10
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:43:31

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		BODY ACTION PRODUCTS Butt Eze Benzocaine	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		PRODUCT MAX GROUP INC	openfda.manufacturer_name
ndc	package	70742-286-00	openfda.package_ndc
ndc	product	70742-286	openfda.product_ndc
ndc11	package	70742028600	derived:openfda.package_ndc
spl id		09d78ab6-7257-6e40-e063-6294a90aef3e	id
spl set id		ba75b129-7939-4373-91f5-1772976e6d61	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with the eyes. Certain persons can develop allergic reactions from ingredients in this product. If the symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, discontinue use and consult a doctor. Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.